Back to search

Switzerland· 48625045

Lodine 300 mg, Filmtabletten

A etodolac product containing etodolacum, registered in Switzerland by Alfasigma Schweiz AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC M01AB08

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLodine 300 mg, FilmtablettenATCM01AB08REGISTER NO.48625045PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Etodolac is registered in 7 of 19 countries.

Countries holding a registration under ATC M01AB08 (etodolac), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 4 of them publish a price we can compare per daily dose

Etodolac · ATC M01AB08

7 / 19 countries

  • Denmark
  • Finlandprice
  • Franceprice
  • Japan
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etodolac costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.43 in France to $0.80 in Switzerland — a ×1.9 gap.

  • Switzerland: $0.80 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Etodolac · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.80
  • FR France$0.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
etodolacum
Manufacturer
Alfasigma Schweiz AG
Country
Switzerland (CH)
ATC code
M01AB08
ATC class
Etodolac
Defined daily dose
0.4 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680486250453
    100 Stk
    CHF 44.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

368 interactions on record for etodolac.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Etodolac · interactions on record

368 records

  • 57 severe
  • 140 moderate
  • 5 minor
  • 85 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etodolac in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etodolac products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Bulgaria · Етодин Форт
  • Denmark · Etodolac "2care4"
  • France · Lodine
  • United Kingdom (Northern Ireland) · Etopan Xl, Lodine Sr
  • Lithuania · Dolait
  • Portugal · Dualgan, Exodolan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b6df748a-d749-4693-b7e6-c7f7ec954620
GET /v1/drugs/b6df748a-d749-4693-b7e6-c7f7ec954620?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "etodolacum 300 mg",
  "valid_from": "1992-03-15",
  "limitations": null,
  "galenic_form": "Filmtabl 300 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1992-03-15",
  "self_retention_pct": 10
}

See everything about etodolac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.